Insider Trading & Ownership - Hoekman John

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Hoekman John

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2023-02-14
Option Award
2023-02-16
6:22 pm
N/A
2033-02-13
IMPEL PHARMACEUTICALS INCIMPLHoekman John
Chief Scientific Officer
42,500$042,500
(Direct)
View
2022-01-26
Option Award
2022-01-28
5:03 pm
N/A
2032-01-25
IMPEL NEUROPHARMA INCIMPLHoekman John
Chief Scientific Officer
35,000$035,000
(Direct)
View
2021-12-22
Exercise
2021-12-23
4:50 pm
N/A
N/A
IMPEL NEUROPHARMA INCIMPLHoekman John
Chief Scientific Officer
20,000$1.64128,221
(Direct)
View
2021-12-22
Exercise
2021-12-23
4:50 pm
N/A
2021-12-22
IMPEL NEUROPHARMA INCIMPLHoekman John
Chief Scientific Officer
20,000$0128,221
(Direct)
View
2021-07-20
Option Award
2021-07-26
5:58 pm
N/A
2031-07-19
IMPEL NEUROPHARMA INCIMPLHoekman John
Chief Scientific Officer
50,000$050,000
(Direct)
View
2021-04-27
Conversion(A)
2021-06-07
4:57 pm
N/A
N/A
IMPEL NEUROPHARMA INCIMPLHoekman John
Chief Scientific Officer
73,910$0108,496
(Direct)
View
2021-04-27
Other
2021-04-29
6:31 pm
N/A
N/A
IMPEL NEUROPHARMA INCIMPLHoekman John
Chief Scientific Officer
275$0178,153
(Direct)
View
2021-04-27
Conversion
2021-04-29
6:31 pm
N/A
N/A
IMPEL NEUROPHARMA INCIMPLHoekman John
Chief Scientific Officer
74,180$0178,153
(Direct)
View
2021-04-27
Exercise
2021-04-29
6:31 pm
N/A
N/A
IMPEL NEUROPHARMA INCIMPLHoekman John
Chief Scientific Officer
8,523$0178,153
(Direct)
View
2021-04-27
Exercise
2021-04-29
6:31 pm
N/A
N/A
IMPEL NEUROPHARMA INCIMPLHoekman John
Chief Scientific Officer
8,523$8.19178,153
(Direct)
View

Ownership
2021-04-22
7:04 pm
N/A
N/A
IMPEL NEUROPHARMA INCIMPLHoekman John
Chief Scientific Officer
0$0556,104
(Direct)
View
(A) Indicate amendment filing.